Tradestie Institutional Equity Comparison Engine
AYTU vs CODX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AYTU Overall Edge
AYTU Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AYTU trades at 9.2x Forward P/E with -14.4% operating margin (+6.4% YoY revenue) versus CODX at 15.4x Forward P/E and -3415.8% operating margin (+94.6% YoY). In options structure, AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CODX sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AYTU
AYTU 9.2x vs CODX 15.4x Fwd P/E
Growth & Margin Winner
AYTU
Op Margin -14.4% vs -3415.8% ยท YoY +6.4% vs +94.6%
Momentum & Technical Winner
AYTU
1Y -12.1% vs -45.5% ยท 52W Pos 5% vs 0%
Options & Structure Winner
AYTU
UNCLASSIFIED (N/A IV) vs BREAKDOWN (50th %ile IV)
AYTU
NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap
$19.6M
1M Return
-11.27%
1Y Return
-12.14%
Forward P/E
9.2x
Unified AI Score
48.9 / 100
HOLD
Tech 49.0
Fund 53.0
Flow 50.0
Mom 64.0
CODX
NASDAQ
Co-Diagnostics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.23
-11.68% 1D
Market Cap
$2.3M
1M Return
-65.08%
1Y Return
-45.54%
Forward P/E
15.4x
Unified AI Score
51.6 / 100
HOLD
Tech 55.0
Fund 54.0
Flow 66.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AYTU -12.14%
CODX -45.54%
Spread: +26.46 pp (AYTU Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AYTU Revenue | CODX Revenue | AYTU Op. Margin | CODX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $0M | -230.1% | -2741.6% | AYTU |
| FY2020 | $30M | $70M | -76.5% | 55.9% | CODX |
| FY2021 | $70M | $100M | -89.7% | 47.1% | CODX |
| FY2022 | $100M | $30M | -113.7% | -78.8% | CODX |
| FY2023 | $110M | $10M | -15.9% | -626.9% | AYTU |
| FY2024 | $70M | $0M | -2.4% | -1023.7% | AYTU |
| FY2025 | $70M | $0M | -11.8% | -8058.8% | AYTU |
| FY2026 | $60M | N/A | -14.4% | N/A | AYTU |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AYTU | CODX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $2.3M | Larger Scale | AYTU |
| Trailing P/E Ratio Valuation | 9.2x | 15.4x | Lower Multiple | AYTU |
| Forward P/E Ratio Valuation | 9.2x | 15.4x | Lower Multiple | AYTU |
| Revenue Growth (YoY) Growth | +6.4% | +94.6% | Higher Growth | CODX |
| Operating Margin (TTM) Profitability | -14.4% | -3415.8% | Higher Margin | AYTU |
| Net Profit Margin Profitability | -24.8% | 0.0% | Higher Margin | CODX |
| Return on Equity (ROE) Capital Efficiency | -52.5% | -192.8% | Higher ROE | AYTU |
| 52-Week Range Position Momentum | 5% ($2โ$3) | 0% ($0โ$14) | Stronger Trend | AYTU |
| Beta / 30D Volatility Risk Regime | 0.65ฮฒ ยท 35% Vol | 2.93ฮฒ ยท 148% Vol | Lower Realized Risk | AYTU |
| Unified Institutional Score Composite Signal | 48.9 / 100 (HOLD) | 51.6 / 100 (HOLD) | Higher Composite | CODX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AYTU vs CODX Buy Guide
AYTU
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CODX
BREAKDOWN
173d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AYTU nor CODX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.